HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
HMGB1 is associated with human cancers and is an activator of autophagy which mediates chemotherapy resistance. We here show that the mRNA levels of HMGB1 are high in leukemia cells and it is involved in the progression of childhood chronic myeloid leukemia (CML). HMGB1 decreases the sensitivity of human myeloid leukemia cells K562 to anti-cancer drug induced death through up-regulating the autophagy pathway, which is confirmed by the observation with an increase in fusion of autophagosomes and autophagolysosomes. When overexpressing HMGB1, both mRNA levels of Beclin-1, VSP34 and UVRAG which are key genes involved in mammalian autophagy and protein levels of p-Bcl-2and LC3-II are increased. Luciferase assays document that over-expression of HMGB1 increases the transcriptional activity of JNK and ERK, which may be silenced by siRNA. The results suggest that HMGB1 regulates JNK and ERK required for autophagy, which provides a potential drug target for therapeutic interventions in childhood CML. [BMB reports 2011; 44(9): 601-606]
Abstract
HMGB1 is associated with human cancers and is an activator of autophagy which mediates chemotherapy resistance. We here show that the mRNA levels of HMGB1 are high in leukemia cells and it is involved in the progression of childhood chronic myeloid leukemia (CML). HMGB1 decreases the sensitivity of human myeloid leukemia cells K562 to anti-cancer drug induced death through up-regulating the autophagy pathway, which is confirmed by the observation with an increase in fusion of autophagosomes and autophagolysosomes. When overexpressing HMGB1, both mRNA levels of Beclin-1, VSP34 and UVRAG which are key genes involved in mammalian autophagy and protein levels of p-Bcl-2and LC3-II are increased. Luciferase assays document that over-expression of HMGB1 increases the transcriptional activity of JNK and ERK, which may be silenced by siRNA. The results suggest that HMGB1 regulates JNK and ERK required for autophagy, which provides a potential drug target for therapeutic interventions in childhood CML. [BMB reports 2011; 44(9): 601-606]
참고문헌 (15)
- Tang, D, "High-mobility group box 1 and cancer", Biochim. Biophys. Acta, 1799, pp.131~140 (2010)
- Tang, D, "Endogenous HMGB1 regulates autophagy", JCB, 6, pp.881~892 (2010)
- Mizushima, N, "Autophagy fights disease through cellular self-digestion", Nature, 451, pp.1069~1075 (2008)
- Levine, B, "Autophagy in the pathogenesis of disease", Cell, 132, pp.27~42 (2008)
- Livesey, K. M, "Autophagy inhibition in combination cancer treatment", Curr. Opin. Investig. Drugs, 10, pp.1269~1279 (2009)
- Carew, J. S, "Clevel and targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis", Clin. Invest, 110, pp.313~322 (2007)
- Xie, M, "Enhancive effect of HMGB1 gene silence on adriamycin-Induced apoptosis in K562", A02 drug resistance leukemia cells, 2008, pp.21, 549~552
- Yu, Y, "Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells", Ai. Zheng, 27, pp.929~933 (2008)
- Liu, L. Y, "HMGB1- induced autophagy promotes chemotherapy resistance in leukemia cells", Leukemia, 25, pp.23~31 (2011)
- Xiongwei Fan, "Cloning and characterization of the cardiac-specific Lrrc10 promoter", BMB reports, 44(2), pp.123~128 (2011), 생화학분자생물학회
- Hanahan, D, "The hallmarks of cancer", Cell, 100, pp.57~70 (2000)
- Funderburk, S. F, "The Beclin1-VPS34-complex - at the cross roads of autophagy and beyond", Cell. Biology, 20, pp.355~362 (2010)
- Kang, R, "HMGB1 -A novel Beclin 1-binding protein active in autophagy", Autophagy, 16, pp.1209~1211 (2010)
- Mizushima, N, "Methods in mammalian autophagy research", Cell, 140, pp.313~326 (2010)
- Liu, L. Y, "DAMP-mediated autophagy contributes to drug resistance", Autophagy, 7, pp.112~114 (2011)